公司资料
Surrozen 股价、新闻与催化剂
- 股票代码:
- SRZN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
23.99 USD (+2.09%)
收盘价
最后更新: 2026年8月21日
269M USD
市值
股价为何变动
As of Aug 21, 2026, SRZN closed up 2.09% at $23.99. No new same-company headline was identified in the current news window.
公司概览
业务概览
Surrozen is a biotechnology company focused on tissue regeneration and organ repair through Wnt biology. Its story centers on whether developmental biology can be translated into therapies for difficult diseases.
所在地与行业分类
Surrozen is headquartered in the United States and listed on NASDAQ. It sits in the regenerative and platform-biotech segment.
商业模式特征
The company depends on translational science, platform validation, and the ability to keep a narrow pipeline funded while it develops its biology. Investors watch early data, strategic changes, and financing needs.
生物医药行业定位
Surrozen occupies a specialized regenerative-biology niche within biotech. The stock is sensitive to whether its platform can move beyond concept toward clinical relevance.
未来催化剂
- Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance. The company is still early and data-dependent.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。